Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.39% |
| 2 | Financials | 6.67% |
| 3 | Healthcare | 6.18% |
| 4 | Industrials | 4.97% |
| 5 | Consumer Discretionary | 4.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CWBC
4201
Community West Bancshares
CWBC
$700M
| $1.49M | ﹤0.01% |
69,203
-31,594
| -31% | -$681K |
|
|
GAN
4202
CALL
DELISTED
GAN Ltd
GAN
| $1.49M | ﹤0.01% |
+100,000
| New | +$1.6M |
|
4203
Nature's Sunshine
NATR
$360M
| $1.49M | ﹤0.01% |
101,487
+17,935
| +21% | +$301K |
|
4204
Amkor Technology
AMKR
$13.9B
| $1.49M | ﹤0.01% |
59,539
-30,702
| -34% | -$783K |
|
|
SOFIW
4205
CALL
DELISTED
SoFi Technologies, Inc. Warrants
SOFIW
| $1.49M | ﹤0.01% |
238,750
-169,627
| -42% | -$1.03M |
|
|
TTOO
4206
DELISTED
T2 Biosystems, Inc
TTOO
| $1.48M | ﹤0.01% |
324
-409
| -56% | -$2.06M |
|
|
CCAIU
4207
DELISTED
Cascadia Acquisition Corp. Unit
CCAIU
| $1.48M | ﹤0.01% |
+150,000
| New | +$1.48M |
|
4208
Cabaletta Bio
CABA
$452M
| $1.48M | ﹤0.01% |
121,624
-868,706
| -88% | -$8.01M |
|
4209
PUT
Regions Financial
RF
$27.3B
| $1.48M | ﹤0.01% |
69,400
-32,200
| -32% | -$641K |
|
4210
CALL
Clover Health Investments
CLOV
$2.25B
| $1.48M | ﹤0.01% |
+200,000
| New | +$1.71M |
|
|
PWOD
4211
DELISTED
Penns Woods Bancorp
PWOD
| $1.48M | ﹤0.01% |
62,083
-39,747
| -39% | -$942K |
|
4212
Teradata
TDC
$3.24B
| $1.47M | ﹤0.01% |
25,701
-30,659
| -54% | -$1.58M |
|
4213
EVgo
EVGO
$244M
| $1.47M | ﹤0.01% |
180,526
+129,575
| +254% | +$1.31M |
|
4214
Marcus & Millichap
MMI
$1.17B
| $1.47M | ﹤0.01% |
36,110
-51,072
| -59% | -$1.98M |
|
|
JBIO
4215
Jade Biosciences
JBIO
$1.3B
| $1.47M | ﹤0.01% |
1,996
+138
| +7% | +$77.3K |
|
4216
Douglas Emmett
DEI
$2B
| $1.47M | ﹤0.01% |
46,386
-307,438
| -87% | -$10.1M |
|
4217
Everest Group
EG
$14.2B
| $1.47M | ﹤0.01% |
5,840
-45,318
| -89% | -$11.6M |
|
4218
Central Pacific Financial
CPF
$1.03B
| $1.46M | ﹤0.01% |
56,995
-31,860
| -36% | -$798K |
|
|
TYME
4219
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
| $1.46M | ﹤0.01% |
1,420,190
-702,388
| -33% | -$773K |
|
4220
Rollins
ROL
$18.2B
| $1.46M | ﹤0.01% |
41,371
-67,982
| -62% | -$2.54M |
|
4221
Microvision
MVIS
$85.2M
| $1.46M | ﹤0.01% |
8,802
+1,551
| +21% | +$323K |
|
|
FACT.U
4222
DELISTED
Freedom Acquisition I Corp. Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant
FACT.U
| $1.46M | ﹤0.01% |
147,435
-495,014
| -77% | -$4.92M |
|
4223
1st Source
SRCE
$2.19B
| $1.46M | ﹤0.01% |
30,860
+12,747
| +70% | +$580K |
|
4224
Norwood Financial Corp
NWFL
$371M
| $1.46M | ﹤0.01% |
56,667
-32,668
| -37% | -$830K |
|
|
HCICW
4225
CALL
DELISTED
Hennessy Capital Investment Corp. V Warrant
HCICW
| $1.46M | ﹤0.01% |
1,165,380
+248,115
| +27% | +$381K |
|
Similar funds
Millennium Management's Q3 2021 Portfolio in Review
As of Q3 2021, Millennium Management held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management deployed $8.65B of net new capital in Q3 2021, opening 1,244 new positions and adding to 2,720 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.
By sector, the portfolio is most concentrated in Technology at 7.4% of assets, down from 7.8% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $694M trimmed.
- Millennium Management's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Millennium Management's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Millennium Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Millennium Management's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Millennium Management opened 1,244 new positions and closed 981 in Q3 2021.
- Millennium Management's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.